计算机化临床决策支持系统对医疗绝对改善的荟萃分析
该系统评价与荟萃分析纳入108项研究(94项随机、14项准随机),涉及1 203 053名患者和10 790名提供者,发现临床决策支持系统使接受推荐诊疗的患者比例绝对提高5.8%(95%CI 4.0%至7.6%),但异质性较大(I2=76%),临床终点改善幅度较小。
要点
- 临床决策支持系统使目标诊疗流程的绝对改善平均为5.8%。
- 在报告临床终点的30项试验中,达到指南目标的中位改善仅0.3%。
- 低基线依从性和儿科环境与更大改善效应相关,但未解释异质性。
核心结论
- 多数临床决策支持系统干预对目标诊疗流程产生小到中等改善,临床终点变化较小。
研究设计与样本
- 系统评价与荟萃分析,纳入108项随机或准随机对照试验(94项随机、14项准随机),共122项试验提供可分析数据,涉及1 203 053名患者和10 790名提供者。
主要发现
- 临床决策支持系统使接受期望诊疗的患者比例绝对提高5.8%(95%CI 4.0%至7.6%),异质性I2=76%。
- 报告改善效果的最高四分位范围为10%至62%。
- 在30项报告临床终点的试验中,达到指南推荐目标(如血压或血脂控制)的患者比例中位改善0.3%(四分位距-0.7%至1.9%)。
- 低基线依从性和儿科环境与显著更大的效应相关,但纳入多变量荟萃回归后未降低异质性。
关键数值与推荐
- 纳入标准为报告临床决策支持系统推荐诊疗的绝对改善百分比的随机或准随机对照试验。
- 采用多水平荟萃分析处理研究内聚类,并用荟萃回归评估特征对异质性的影响。
临床怎么用
- 临床决策支持系统可小幅提升指南推荐诊疗的执行率,但临床终点获益有限,需结合具体场景评估。
局限性
- pooled效应异质性大(I2=76%),预测更显著改善的因素尚未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report the improvements achieved with clinical decision support systems and examine the heterogeneity from pooling effects across diverse clinical settings and intervention targets. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline up to August 2019. ELIGIBILITY CRITERIA FOR SELECTING STUDIES AND METHODS: Randomised or quasi-randomised controlled trials reporting absolute improvements in the percentage of patients receiving care recommended by clinical decision support systems. Multilevel meta-analysis accounted for within study clustering. Meta-regression was used to assess the degree to which the features of clinical decision support systems and study characteristics reduced heterogeneity in effect sizes. Where reported, clinical endpoints were also captured. RESULTS: In 108 studies (94 randomised, 14 quasi-randomised), reporting 122 trials that provided analysable data from 1 203 053 patients and 10 790 providers, clinical decision support systems increased the proportion of patients receiving desired care by 5.8% (95% confidence interval 4.0% to 7.6%). This pooled effect exhibited substantial heterogeneity (I2=76%), with the top quartile of reported improvements ranging from 10% to 62%. In 30 trials reporting clinical endpoints, clinical decision support systems increased the proportion of patients achieving guideline based targets (eg, blood pressure or lipid control) by a median of 0.3% (interquartile range -0.7% to 1.9%). Two study characteristics (low baseline adherence and paediatric settings) were associated with significantly larger effects. Inclusion of these covariates in the multivariable meta-regression, however, did not reduce heterogeneity. CONCLUSIONS: Most interventions with clinical decision support systems appear to achieve small to moderate improvements in targeted processes of care, a finding confirmed by the small changes in clinical endpoints found in studies that reported them. A minority of studies achieved substantial increases in the delivery of recommended care, but predictors of these more meaningful improvements remain undefined.
引用
- Kwan JL, Lo L, Ferguson J, et al. Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ. 2020. PMID: 32943437. doi:10.1136/bmj.m3216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。